Fixing the Leak: An Opioid Treatment for Dopamine Disorders?
A breakthrough by ÑDz©¹ÙÍø researchers shows that blocking the kappa opioid receptor improves behavioral deficits tied to ADHD, autism and bipolar disorder, providing a potentially safer yet effective treatment.
ÑDz©¹ÙÍø's Stiles-Nicholson Brain Institute Hosts 'Brainy Days' Celebration
ÑDz©¹ÙÍø's Stiles-Nicholson Brain Institute will celebrate advancements in brain science and health with its annual "Brainy Days" events throughout the month of March.
Fluorescent Probes Illuminate Cholesterol and Alzheimer's Research
ÑDz©¹ÙÍø researchers have developed cutting-edge fluorescent cholesterol probes, which now enable them to visualize cholesterol movement and distribution in live cells with unprecedented detail.
'Ding-Dong:' A Study Finds Specific Neurons With an Immune Doorbell
ÑDz©¹ÙÍø neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system.
ÑDz©¹ÙÍø's Randy D. Blakely, Ph.D., Honored as a Prestigious ASPET Fellow
Randy D. Blakely, Ph.D., a highly regarded neuroscientist and pharmacologist, is among an extraordinary group selected by the American Society for Pharmacology and Experimental Therapeutics.
ÑDz©¹ÙÍø Adds State-of-the-Art MRI System to Advance Research Capabilities
ÑDz©¹ÙÍø has added a new state-of-the-art MRI system to its research infrastructure, marking a transformative step forward for groundbreaking studies in neuroscience, clinical health and medical advancements.
Master Copper Regulator Discovery May Offer Alzheimer's Clues
A groundbreaking study by ÑDz©¹ÙÍø researchers using a tiny roundworm, links the worm gene swip-10 to copper regulation, which could pave the way for new treatments for neurodegenerative disorders.
ÑDz©¹ÙÍø Ranks Among 'Washington Monthly' Top Public, Private Universities
ÑDz©¹ÙÍø has been ranked No. 41 overall among the nation's best public and private universities by Washington Monthly.
A 'One in a Million' Shot to Tackle Dopamine-Linked Brain Disorders
With the help of a tiny, transparent worm, ÑDz©¹ÙÍø researchers have identified novel players in dopamine signaling by taking advantage of a powerful platform generated via the Million Mutation Project (MMP).
'Fit2Drive' Transforms Assessing Older Drivers with Cognitive Decline
"Fit2Drive," an algorithm developed by ÑDz©¹ÙÍø researchers has made it easy to administer and evaluate an in-office test to predict an older individual's probability of passing an on-road driving test.